Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-26 pm EST
27.96 USD   -0.07%
01/26Twist Bioscience Says Oregon Manufacturing Facility Starts Shipments
MT
01/26Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
BU
01/19Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Top Premarket Decliners

11/15/2022 | 08:08am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMMO, INC. 3.06% 2.36 Delayed Quote.32.37%
DAXOR CORPORATION 0.55% 9.06 End-of-day quote.-1.09%
EXELA TECHNOLOGIES, INC. -3.62% 0.0718 Delayed Quote.-12.44%
TWIST BIOSCIENCE CORPORATION -0.07% 27.96 Delayed Quote.17.51%
VERSUS SYSTEMS INC. -21.50% 0.628 Delayed Quote.29.35%
All news about TWIST BIOSCIENCE CORPORATION
01/26Twist Bioscience Says Oregon Manufacturing Facility Starts Shipments
MT
01/26Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Fa..
BU
01/19Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, Febru..
BU
01/10Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Heredita..
BU
01/10Twist Bioscience and Centogene Launch Three Panels to Advance Rare Disease and Heredita..
CI
01/09Transcript : Twist Bioscience Corporation Presents at 41st Annual J.P. Morgan..
CI
01/09Twist Bioscience Enters Into Research Collaboration Project With Astellas Pharma
MT
01/09Twist Bioscience : JP Morgan 2023 FINAL
PU
01/09Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collab..
BU
01/09Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collab..
CI
More news
Analyst Recommendations on TWIST BIOSCIENCE CORPORATION
More recommendations
Financials (USD)
Sales 2023 266 M - -
Net income 2023 -260 M - -
Net cash 2023 225 M - -
P/E ratio 2023 -6,13x
Yield 2023 -
Capitalization 1 584 M 1 584 M -
EV / Sales 2023 5,12x
EV / Sales 2024 3,97x
Nbr of Employees 989
Free-Float 98,9%
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 27,96 $
Average target price 35,88 $
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Emily Marine Leproust Chairman & Chief Executive Officer
Patrick J. Finn President & Chief Operating Officer
James M. Thorburn Chief Financial Officer
Aaron K. Sato Chief Scientific Officer
Siyuan Chen Chief Technology Officer
Sector and Competitors